Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 157

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 7
Chunk 157
---

Item 7.   Major Shareholders and Related Party Transactions
-----------------------------------------------------------

A.   Major shareholders
-----------------------
 
We are not directly or indirectly owned or controlled by another corporation or by any foreign government. Based on filings with the SEC and the Canadian securities regulatory authorities, as at March 26, 2025, no individual or entity, other than as set out below, beneficially owned, directly or indirectly, or exercised control or direction over our Common Shares carrying more than 5% of the voting rights attached to all our Common Shares (to whom we refer as our major shareholders).
  
Changes in Percentage Ownership by Major Shareholders
 
On July 1, 2020, Intracoastal Capital LLC became a major shareholder due to the acquisition of over 5% of our outstanding Common Shares, but as of December 31, 2021 ceased to beneficially own more than 5% of our Common Shares, based solely on a Schedule 13G filed with the SEC on February 11, 2022. On July 2, 2020, Lind Global Macro Fund, LP became a major shareholder due to the acquisition of over 5% of our outstanding Common Shares, but as of December 31, 2021 ceased to beneficially own more than 5% of our Common Shares, based solely on a Schedule 13G filed with the SEC on February 11, 2022. As of the close of business on June 5, 2024, Goodwood Fund, together with its affiliate and control person, became a major shareholder due to its beneficial ownership of over 5% of our outstanding Common Shares. Based solely on a Schedule 13DA filed on December 20, 2024, Goodwood Fund LP, together with its affiliates and control person, held approximately 8.2% of our outstanding Common Shares as of December 20, 2024.
United States Shareholders
 
Based on a review of the information provide to us by our transfer agent, as at March 26, 2025, there were [14] holders of record of our Common Shares, of which [two] were registered with an address in the U.S., holding in the aggregate approximately 99% of our outstanding Common Shares. We believe that the number of beneficial owners of our Common Shares is substantially greater than the number of record holders, because the overwhelming majority of our Common Shares are held in broker “street names”.

B.   Related party transactions
-------------------------------
 
During